1 / 34

Colorectal Cancer

Epidemiology. Second leading cause of cancer death in US - approx 148,000 cases/yr and 58,000 deathsEqual lifetime risk between men and women93% of cases dx over age 50. Five-year survival of 60%Treatment costs over $6.5 billion per year Among malignancies, second only to breast cancer at $6.6 billion per year.

uttara
Télécharger la présentation

Colorectal Cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Colorectal Cancer Niraj Jani, MD Div of Gastroenterology Sinai Hospital

    2. Epidemiology Second leading cause of cancer death in US - approx 148,000 cases/yr and 58,000 deaths Equal lifetime risk between men and women 93% of cases dx over age 50. Five-year survival of 60% Treatment costs over $6.5 billion per year Among malignancies, second only to breast cancer at $6.6 billion per year

    3. Epidemiology Industrialized nations have the greatest risk

    4. Pathogenesis Adenoma to Carcinoma sequence:

    5. Pathogenesis Adenomatous polyps and adenocarcinoma are epithelial tumors of the large intestine Risk factors for polyps/adenomas to develop into cancer: Patient age (greatly increased after 50 yo, with prevalence doubling until age 80) Adenomas greater than 1 cm Extensive villous patterns

    6. Pathogenesis

    7. CRC Risk Factors Age: CRC incidence increases rapidly after 50 years of age Adenomatous Polyps: 30% at 50 years, 40-50% at 60 years, and up to 65% at 70 years Most importantly, the risk of HGD in a polyp is 80% higher in an older person than younger person

    8. CRC Risk Factors Diet: Greatest association is between high fat diet/red meat and CRC High cholesterol, obesity linked to CRC A prospective study of more than 760,000 people showed diets rich in vegetables and high fiber grains demonstrated significant protection against fatal CRC

    9. Diet and Colon Cancer Protective factors: Fiber: decreases fecal transit time by increasing stool bulk Dilutes the concentration of other colonic constituents which minimizes interactions btwn carcinogens and colon epithelium Reduces colonic pH and generates short chain fatty acids

    10. CRC Risk Factors Other risk factors: Hx of Ulcerative Colitis Strep Bovis infection Ureterosigmoidostomy Dermatomyositis Pelvic Irradiation Smoking/ETOH consumption Obesity

    11. CRC Protective Factors Other protective factors: Exercise NSAIDs/ASA Folate High calcium intake Hormonal therapy Selenium

    12. CRC Risk Factors Genetics:

    13. CRC Risk Factors Familial clustering present in 15% of all cases of CRC Increased risk 1.5-2.0 fold Individuals with hx of adenomas are at three to sixfold increased risk of metachronous neoplasms

    14. Genetic Sydromes Familial adenomatous polyposis (FAP): an inherited condition caused by a germline mutation on chromosome 5 (APC gene) Leads to hundreds to thousands of polyps throughout the GI tract Other findings include: - duodenal adenomas - fundic gland hyperplasia - mandibular osteomas - supernumerary teeth

    15. FAP

    16. Genetic Sydromes Attenuated FAP: (<100 adenomas) and later onset of CRC Turcot’s Syndrome: familial predisposition for colonic polyposis and CNS tumors Gardner’s Syndrome: variant of FAP Osteomas of the skull and long bones (CHRPE) Congenital Hypertrophy of the Retinal Pigmented Epithelium

    17. Genetic Sydromes Hereditary nonpolyposis colorectal cancer (HNPCC) syndrome: also called Lynch syndrome: characterized by proximal cancer in 3rd and 4th decade of life Also associated with extracolonic cancers- (uterus, ovaries, stomach, small bowel and bile duct) Mutations in DNA mismatch repair genes (MLH1, MSH2)

    18. HNPCC Amsterdam Criteria for Dx of HNPCC > 3 relatives with HNPCC related cancers 2. > 1 case is a first-degree relative of 2 other cases 3. > 2 successive generations affected 4. > 1 case diagnosed before age 50 years

    19. Genetic Sydromes Other Genetic Diseases linked to CRC: Muir-Torre Syndrome Peutz-Jeghers Syndrome Tuberous Sclerosis Juvenile Polyposis Sydrome Cowden disease Cronkhite-Canada Syndrome

    20. Screening Annual Fecal Occult Blood Test (FOBT) Flexible Sigmoidoscopy every 5 years Annual FOBT + Flexible Sigmoidoscopy every 5 years Colonoscopy every 10 years Double Contrast Barium Enema (DCBE) every 5 years

    21. FOBT Uses the peroxidase activity of hemoglobin to cause a change in a reagent Consume diets high in fiber, restrict red meat consumption, vitamin C, and NSAID drugs for several days prior to testing The sensitivity of fecal occult blood testing ranges from 30–92% with a specificity of 98%

    22. Barium Enema

    23. Flexible Sigmoidoscopy Colonoscope inserted to the descending colon 60% of all neoplasms are within this distribution- therefore, flex sigmoidoscopy along with FOBT provides an effective screening tool Minimal prep and no sedation required; office procedure performed by internists, fam med docs, NPs Perforation risk: 1-2/10,000

    24. Colonoscopy Gold standard for CRC screening Risk of complications: 0.1–0.3% risk of hemorrhage and perforation Allows for mucosal biopsy, polypectomy, tattooing, accurate localization and flushing/suctioning Sensitivity of colonoscopy for the detection of polyps greater than or equal to 1 cm and tumors is greater than 95%

    25. Colonoscopy

    26. Chemoprevention COX-II inhibitors Estrogens Ursodeoxycholic Acid

    27. Adenocarcinoma

    28. Treatment Primary treatment for early colon cancer is surgery. For rectal cancer, total mesorectal excision In tumors that are > T3 or > N1, preoperative chemo is recommended Radiation is useful in rectal cancer, not colon cancer

    29. CRC Treatment Common chemotherapeutic regimen includes 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) Other agents include bevacizumab, cetuximab,irinotecan, capecitabine

    30. Question 1 A 32 yo male presents for annual health maintenance visit. His mother was dx with colon cancer at age 55. Patient should undergo screening at what age? A. Now 40 yo 45 yo 50 yo

    31. Question 1 Pt has a twofold increase in CRC compared to age matched controls due to first degree relative with cancer Guideline- screen ten years before first-degree relative or at age 40 depending on which comes first

    32. Question 2 Three months ago, a 62 yo BM underwent a flex sig and was found to have an obstructing mass. He underwent a sigmoid resection which was considered curative. Did not receive post-op chemo/radiation. Which is the most appropriate CRC surveillance procedure for this pt? A. Colonoscopy Now B. Colonoscopy In 1 year C. Colonoscopy In 3 years D. CT Abdomen now E. CT Abdomen in 3 years

    33. Question 2 Synchronous cancers occur in 3-5% of pts found to have CRC Pt never had colonoscopy previously Once resection performed- repeat colon in 1 year then 3 year intervals Abdominal CT yearly for 3 years

    34. Question 3 The test of choice for screening 1rst degree relatives of pts with FAP is: Colonoscopy starting at age 12 every 5 years Genetic testing at age 10 to 12 yo Sigmoidoscopy starting at age 12 every year Sigmoidoscopy starting at age 20 every year No screening

    35. Question 3 Genetic testing for a mutation in the APC gene if the first screening test. If genetic testing is not available, then sigmoidoscopy starting at age 12

More Related